MARKET

DWTX

DWTX

Dogwood Therapeutics
NASDAQ
1.480
-0.030
-1.99%
After Hours: 1.560 +0.08 +5.41% 19:57 06/25 EDT
OPEN
1.530
PREV CLOSE
1.510
HIGH
1.543
LOW
1.450
VOLUME
15.45K
TURNOVER
--
52 WEEK HIGH
9.50
52 WEEK LOW
1.280
MARKET CAP
49.77M
P/E (TTM)
-0.1396
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at DWTX last week (0615-0619)?
Weekly Report · 3d ago
Dogwood Therapeutics Shareholders Approve Key Governance Measures
TipRanks · 06/17 22:32
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 06/17 21:06
Dogwood Therapeutics shareholders approve charter amendment increasing authorized shares
PUBT · 06/17 20:56
Weekly Report: what happened at DWTX last week (0608-0612)?
Weekly Report · 06/15 09:26
Dogwood Therapeutics posts corporate presentation on non-opioid pain, neuropathy drug pipeline
PUBT · 06/12 13:43
Weekly Report: what happened at DWTX last week (0601-0605)?
Weekly Report · 06/08 09:24
Weekly Report: what happened at DWTX last week (0525-0529)?
Weekly Report · 06/01 09:26
More
About DWTX
Dogwood Therapeutics, Inc. is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and fatigue-related disorders. The Company’s research pipeline includes two separate mechanistic platforms with a non-opioid analgesic program and an antiviral program. The proprietary, non-opioid, Nav 1.7 analgesic program is centered on its lead development candidate, Halneuron, which is a specific voltage-gated sodium channel modulator, a mechanism known to be effective for reducing pain transmission. In clinical studies, Halneuron treatment has demonstrated pain reduction in pain related to general cancer and in pain related to chronic chemotherapy-induced neuropathic pain (CINP). The Company’s antiviral program includes IMC-1 and IMC-2, which are fixed-dose combinations of nucleoside analog, anti-herpes antivirals and the anti-inflammatory agent celecoxib for the treatment of fibromyalgia (FM) and Long-COVID (LC).

Webull offers Dogwood Therapeutics Inc stock information, including NASDAQ: DWTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DWTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DWTX stock methods without spending real money on the virtual paper trading platform.